ACTN3 Genotype Association with Motoric Performance of Roma Children

Authors: J. Bernasovska, I. Boronova, J. Poracova, M. Mydlarova Blascakova, V. Szabadosova, P. Ruzbarsky, E. Petrejcikova, I. Bernasovsky

Abstract:

The paper presents the results of the molecular genetics analysis in sports research, with special emphasis to use genetic information in diagnosing of motoric predispositions in Roma boys from East Slovakia. The ability and move are the basic characteristics of all living organisms. The phenotypes are influenced by a combination of genetic and environmental factors. Genetic tests differ in principle from the traditional motoric tests, because the DNA of an individual does not change during life. The aim of the presented study was to examine motion abilities and to determine the frequency of ACTN3 (R577X) gene in Roma children. Genotype data were obtained from 138 Roma and 155 Slovak boys from 7 to 15 years old. Children were investigated on physical performance level in association with their genotype. Biological material for genetic analyses comprised samples of buccal swabs. Genotypes were determined using Real Time High resolution melting PCR method (Rotor-Gene 6000 Corbett and Light Cycler 480 Roche). The software allows creating reports of any analysis, where information of the specific analysis, normalized and differential graphs and many information of the samples are shown. Roma children of analyzed group legged to non-Romany children at the same age in all the compared tests. The % distribution of R and X alleles in Roma children was different from controls. The frequency of XX genotype was 9.26%, RX 46.33% and RR was 44.41%. The frequency of XX genotype was 9.26% which is comparable to a frequency of an Indian population. Data were analyzed with the ANOVA test.

Keywords: ACTN3 gene, R577X polymorphism, Roma children, Slovakia, sports performance.

Digital Object Identifier (DOI): doi.org/10.5281/zenodo.1125457

References:

[1] N. Yang, D. G. MacArthur, J. P. Gulbin, A. G. Hahn, A. H. Beggs, S. Easteal and K. North, “ACTN3 genotype is associated with human elite athletic performance,” AJHG, vol. 73, no. 3, pp. 627-631, 2003.
[2] M. Mills, N. Zang, R. Weinberger, D. L. Vander Woude, A. H. Beggs, S. Easteal and K. North, “Differential expression of the actin-binding proteins, -actinin-2 and 3-, in different species: implications for the evolution of functional redundancy,” Hum. Mol. Genet., vol. 10, no. 13, pp. 1335-1346, 2001.
[3] K. N. North, N. Zang and A. H. Beggs, “Deficiency of a skeletal muscle isoform of actinin (a-actinin-3) in merosin positive congenital muscular dystrophy„ Neuromuscular Disord., vol. 6, no. 4, pp. 229-235, 1996.
[4] K. North, N. Yang, D. Wattanasirichaigoon, M. Mills, S. Easteal and A. H. Beggs, “A common nonsense mutation results in alpha-actinin-3 deficiency in the general population,” Nature Genet., vol. 21, pp. 353- 354, 1999.
[5] K. H. Myburgh, “What makes an endurance athlete world-class? Not simply a physiological conundrum,” Comparative Biochemistry and Physiology, vol. 136, pp. 171-190, 2003.
[6] D. G. MacArthur and K. N. North, “ACTN3: A genetic influence on muscle function and athletic performance,” Exercise and Sport Sciences reviews, vol. 35, no.1, pp. 30-34, 2007.
[7] Ch. Livingstone, “Genetics and molecular biology of muscle adaptation,” Elsevier limited, pp. 273, 2006.
[8] J.T. Seto, M. Lek, K.G. Quinlan, P.J. Houweling, X.F. Zheng, F. Garton, D.G. MacArthur, J.M. Raftery, S.M. Garvey, N. Hauser, M.A. Yang, S.I. Head, K.N. North, “Deficiency of alpha-actinin-3 is associated with increased susceptibility to contraction-induced damage and skeletal muscle remodeling,” Hum Mol Genet, vol. 20, no. 15, pp. 2914–2927, 2011.
[9] P.M. Clarkson, J.M. Devaney, H. Gordish-Dressman, P.D. Thompson, M.J. Hubal, M. Urso, T.B. Price, T.J. Angelopoulos, P.M. Gordon, N.M. Moyna, L.S. Pescatello, P.S. Visich, R.F. Zoeller, R.L. Seip, E.P. Hoffman, “ACTN3 genotype is associated with increases in muscle strength in response to resistance training in women,” J Appl Physiol, vol. 99, no. 1, pp. 154–163, 2005.
[10] I.I. Ahmetov, A.M. Druzhevskaya, E.V. Lyubaeva, D.V. Popov, O.L. Vinogradova, A.G. Williams, “The dependence of preferred competitive racing distance on muscle fibre type composition and ACTN3 genotype in speed skaters,” Exp Physiol, vol. 96, pp. 1302–1310, 2011.
[11] D.G. MacArthur, J.T. Seto, S. Chan, K.G. Quinlan, J.M. Raftery, N. Turner, M.D. Nicholson, A.J. Kee, E.C. Hardeman, P.W. Gunning, G.J. Cooney, S.I. Head, N. Yang, K.N. North, “An Actn3 knockout mouse provides mechanistic insights into the association between alpha-actinin- 3 deficiency and human athletic performance, » Hum Mol Genet, vol. 17, pp. 1076–1086, 2008.
[12] A. J. Cuticchia, “Genetics”, A Handbook for Lawyers. ABA Publishing Chicago, pp. 221, 2009.
[13] A. K. Niemi and K. Majamaa, “Mitochondrial DNA and ACTN3 genotypes in Finnish elite endurance and sprint athletes,“ Europ. J. Hum. Genet., vol. 13, pp. 965-969, 2005.
[14] H. Goel, B. Mittal, “ACTN3 gene: Athlete gene prevalence in North India,” Current Science, vol. 84, no. 92, January 2007.
[15] N. Eyon, J. A. Duarte,” ACTN3 R577X polymorphism and Israeli Toplevel athletes,” Inter J Sports Med, vol. 30, no. 8, pp. 695-698, September 2009.
[16] A. Lucia, J. Esteve-Lanao, J. Oliván, F. Goméz-Gallego, A. F. San Juan, C. Santiago, M. Pérez, C. Chamorro-Viňa and C. Foster, “Physiological characteristics of the best Eritrean runners-exceptional running economy„ Appl. Phys. Nutr. and Metab., vol. 31,no. 5,pp. 530-540, 2006.
[17] C. J. Saunders, A. V. September, S. L. Xenophontos, M. A. Cariolou, L. C. Anastassiades, T. D. Noakes and M. Collins, “No association of the ACTN3 gene R577X polymorphism with endurance performance in Ironman Triathlons,” Ann. Hum. Gen., vol. 71, no. 6, pp. 777-781, 2007.
[18] C. N. Moran, N. Yang, M. E. S. Bailey, A. Tsiokanos, A. Jamurtas, D. G. MacArthur, K. North, Y. P. Pitsiladis, R. H. Wilson, “Association analysis of the ACTN3 R577X polymorphism and complex quantitative body composition and performance phenotypes in adolescent Greeks,” Eur J Hum Genet, vol. 15, pp. 88-93, October 2006.
[19] B. Norman, M. Esbjörnsson, H. Rundqvist, T. Österlund, B. Glenmark, E. Jansson, “ACTN3 genotype and modulation of skeletal muscle response to exercise in human subjects,” Journal of Applied Physiology, vol. 116, no. 9, pp. 1197-1203, 2014.
[20] E.M. Pimenta, D.B. Coelho, I.R. Cruz, R.F. Morandi, C.E. Veneroso, G. de Azambuja Pussieldi, M.R. Carvalho, E. Silami-Garcia, J.A. De Paz Fernández, “The ACTN3 genotype in soccer players in response to acute eccentric training,” Eur J Appl Physiol, vol. 112, pp. 1495–1503, 2012.
[21] R.J. Urban, “Growth hormone and testosterone: anabolic effects on muscle,” Horm Res Paediatr, vol. 76(Suppl 1), pp. 81–83, 2011.
[22] S. Walsh, D. Liu, E.J. Metter, L. Ferrucci, S.M. Roth, “ACTN3 genotype is associated with muscle phenotypes in women across the adult age span” J Appl Physiol, vol. 105, pp. 1486–1491, 2008.
[23] H. Zempo, K. Tanabe, H. Murakami, M. Iemitsu, S. Maeda, S. Kuno, “ACTN3 polymorphism affects thigh muscle area,” Int J Sports Med, vol. 31, pp. 138–142, 2010.
[24] T. Rankinen, M. S. Bray, J. M. Hagberg, L. Pérusse, S. M. Roth, B. Wolfarth, C. Bouchard, “The human gene map for performance and health-related fitness phenotypes:the 2005 update,” Official Journal of the American College of Sports Medicine, pp.1863-1888, 2005.